MoneyWorks4Me

Crisil assigns ‘A1+’ rating to commercial paper of Sun Pharma

05 Oct 2017 Evaluate

Credit rating agency, Crisil has assigned ‘A1+’ rating to Commercial Paper of Sun Pharmaceutical Industries. The rating agency has also reaffirmed ratings of ‘AAA/Stable’ and ‘A1+’ on the long term and short term bank facilities of the company, respectively.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Peers
Company Name CMP
Sun Pharma. Inds. 1791.30
Dr. Reddys Labs. 1212.60
Cipla 1341.85
Lupin 2009.95
Zydus Lifesciences 1153.80
View more..